Kenvue Inc. Files Proxy Statement Supplement
Ticker: KVUE · Form: DEFA14A · Filed: 2025-05-07T00:00:00.000Z
Sentiment: neutral
Topics: proxy-statement, annual-meeting, sec-filing
Related Tickers: KVUE
TL;DR
Kenvue filed a proxy supplement for its 2025 shareholder meeting. Details inside.
AI Summary
Kenvue Inc. filed a supplemental proxy statement on May 7, 2025, for its 2025 Annual Meeting of Stockholders. This document, filed as definitive additional materials, supplements the proxy statement originally dated May 7, 2025. The filing is made under Schedule 14A of the Securities Exchange Act of 1934.
Why It Matters
This filing provides updated or additional information to shareholders regarding the upcoming 2025 Annual Meeting, ensuring they have the most current details for voting.
Risk Assessment
Risk Level: low — This is a routine administrative filing related to a shareholder meeting, not indicating any immediate financial or operational risks.
Key Players & Entities
- Kenvue Inc. (company) — Registrant
- 0001944048-25-000126.txt (document) — Filing document identifier
- May 7, 2025 (date) — Filing date and meeting date reference
- Schedule 14A (regulation) — SEC filing schedule
- Securities Exchange Act of 1934 (regulation) — Governing act for the filing
FAQ
What type of filing is this?
This is a DEFA14A filing, specifically a Definitive Additional Materials filing, which supplements a proxy statement.
Who is the registrant?
The registrant is Kenvue Inc.
When was this supplemental filing made?
This supplemental proxy statement was filed on May 7, 2025.
What meeting does this filing relate to?
This filing relates to the 2025 Annual Meeting of Stockholders of Kenvue Inc.
Under which SEC act and schedule is this filing made?
This filing is made under the Securities Exchange Act of 1934, pursuant to Schedule 14A.
From the Filing
0001944048-25-000126.txt : 20250507 0001944048-25-000126.hdr.sgml : 20250507 20250507153135 ACCESSION NUMBER: 0001944048-25-000126 CONFORMED SUBMISSION TYPE: DEFA14A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20250507 DATE AS OF CHANGE: 20250507 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Kenvue Inc. CENTRAL INDEX KEY: 0001944048 STANDARD INDUSTRIAL CLASSIFICATION: PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844] ORGANIZATION NAME: 03 Life Sciences EIN: 881032011 STATE OF INCORPORATION: DE FISCAL YEAR END: 1228 FILING VALUES: FORM TYPE: DEFA14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-41697 FILM NUMBER: 25920982 BUSINESS ADDRESS: STREET 1: 1 KENVUE WAY CITY: SUMMIT STATE: NJ ZIP: 07901 BUSINESS PHONE: 908-874-1200 MAIL ADDRESS: STREET 1: 1 KENVUE WAY CITY: SUMMIT STATE: NJ ZIP: 07901 FORMER COMPANY: FORMER CONFORMED NAME: JNTL, Inc. DATE OF NAME CHANGE: 20220825 DEFA14A 1 kenvue-proxysupplement.htm DEFA14A Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 ☑ Filed by the Registrant ☐ Filed by a Party other than the Registrant Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy Statement ☑ Definitive Additional Materials ☐ Soliciting Material under Rule 14a-12 Kenvue Inc. (Name of registrant as specified in its charter) (Name of person(s) filing proxy statement, if other than the registrant) Payment of Filing Fee (Check all boxes that apply): ☑ No fee required ☐ Fee paid previously with preliminary materials ☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 SUPPLEMENT TO DEFINITIVE PROXY STATEMENT DATED MAY 7, 2025 FOR THE 2025 ANNUAL MEETING OF STOCKHOLDERS This proxy statement supplement, dated May 7, 2025 (this “Supplement”), amends and restates the disclosure in the Definitive Proxy Statement (the “Proxy Statement”) of Kenvue Inc. (the “Company”) for the 2025 Annual Meeting of Stockholders (the “Annual Meeting”), filed with the Securities and Exchange Commission on April 9, 2025, under the heading “Certain Related Persons Transactions with Directors” relating to a description of certain relationships between the Company, directors and certain third parties (the “Supplemental Disclosure”). The Supplemental Disclosure should be read in conjunction with the Proxy Statement.   The Supplemental Disclosure does not change the proposals to be acted on at the Annual Meeting or the recommendation of the Board of Directors with respect to any proposals. Except as specifically amended and restated by the Supplemental Disclosure contained herein, this Supplement does not revise or update any of the other information set forth in the Proxy Statement. This Supplement does not provide all of the information that is important to your voting decisions at the Annual Meeting, and the Proxy Statement contains other important additional information. Capitalized terms used in the Supplemental Disclosure and not otherwise defined herein have the meanings given to them in the Proxy Statement.   The information under the heading “Certain Related Persons Transactions with Directors” on page 95 of the Proxy Statement is amended and restated to read as follows: Ms. Hofstetter is the president of Profitero, Ltd. (“Profitero”), a subsidiary of Publicis Groupe S.A. (“Publicis”). Kenvue paid Profitero approximately $1.2 million in 2024 in connection with ordinary course business transactions involving market data analytics, which represented substantially less than 2% of Publicis’ 2024 consolidated gross revenues. The transactions involved Profitero